Momenta Pharm Stock Price, News & Analysis

MNTA NASDAQ

Company Description

Momenta Pharm (NASDAQ: MNTA) is a publicly traded biotechnology company in the Health Technology sector.

MNTA stock has gained 304.9% over the past year.

This page provides a comprehensive overview of MNTA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+304.94%

Performance 1 year

$0.0

Market Cap

119.0M

Shares outstanding

Momenta Pharm (MNTA) stock. Over the past 12 months, the stock has gained 304.9%.

Latest News

View All

September 15, 2020

+0.52%

Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson & Johnson

August 19, 2020

+69.17%

Momenta Enters Definitive Agreement with Johnson & Johnson

August 3, 2020

+9.70%

Momenta Pharmaceuticals Announces Date of Second Quarter 2020 Financial Results Conference Call and Webcast

conferences earnings

July 28, 2020

-0.53%

Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN

fda approval

June 15, 2020

+14.81%

Momenta Pharmaceuticals Announces Positive Topline Data from Interim Analysis of Phase 2 Vivacity-MG Study of Nipocalimab (M281) in Generalized Myasthenia Gravis (gMG)

clinical trial

May 7, 2020

-3.17%

Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results

earnings

Momenta Pharm has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences, earnings, fda approval, clinical trial. View all MNTA news →

SEC Filings

View All

No SEC filings available for MNTA.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MNTA Company Profile & Sector Positioning

Momenta Pharm (MNTA) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.